Chlorphenesin carbamate

氯苯甘油氨酯

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameChlorphenesin carbamate
Drug Alias NameMaolateRinlaxer
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsMusculoskeletal PainMuscle Spasticity
Global Approved IndicationsMusculoskeletal PainMuscle Spasticity
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1979/03/13
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMusculoskeletal PainMuscle Spasticity
Inactive IndicationsN/A

Other Information

ATC CodeD01AE07